BRIEF-Newlink Genetics says Roche Group member Genentech informed co that it intends to return rights to IDO … – Reuters

June 8 Newlink Genetics Corp

* Newlink Genetics - on June 6, Genentech, a member of Roche Group, informed co that it intends to return rights to IDO inhibitor GDC-0919

* Newlink Genetics - rights co had licensed to genentech with respect to GDC-0919 will revert to co when termination becomes effective

* Newlink Genetics - research collaboration with Genentech for discovery of next generation IDO/TDO (tryptophan 2,3-dioxygenase) inhibitors continues Source text for Eikon: Further company coverage:

* Bain, Western Digital in group led by Japan state fund -sources

June 8 BlackRock Inc said on Thursday it hired Goldman Sachs' Heather Brownlie as its U.S. head of fixed-income ETFs.

Excerpt from:
BRIEF-Newlink Genetics says Roche Group member Genentech informed co that it intends to return rights to IDO ... - Reuters

Related Posts